Latest / Cyrona Cell Podcast: Stem Cell Therapy in Malaysia

New Wharton’s Jelly MSC Study: Why Cell Quality Testing Matters in Stem Cell Therapy
In this episode, we break down a new 2026 Wharton’s jelly mesenchymal stem cell (MSC) study and explain why cell potency testing may be just as important as the stem cells themselves in determining treatment success.
You’ll learn:
What the 2026 Scientific Reports study found in patients with steroid-resistant graft-versus-host disease (GvHD)
Why Wharton’s jelly MSCs are widely used in immune-related conditions
How potency assays measure the real functional quality of stem cell batches
Why were higher potency scores linked to significantly better patient outcomes
How MSC response rates compare…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.